Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription

Articles published in J Rheumatol

Retrieve available abstracts of 132 articles:
HTML format

Single Articles

    June 2022
    The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220412. doi: 10.3899/jrheum.220412.
    PubMed     Abstract available

  2. AVOUAC J, Molto A, Frantz C, Wanono S, et al
    Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220073. doi: 10.3899/jrheum.220073.
    PubMed     Abstract available

  3. MOORE MN, Wallace BI, Song J, Muhammad LN, et al
    Correlation of fibromyalgia survey questionnaire and quantitative sensory testing among patients with active rheumatoid arthritis.
    J Rheumatol. 2022 Jun 1. pii: jrheum.220046. doi: 10.3899/jrheum.220046.
    PubMed     Abstract available

  4. DARABIAN S, Wade JP, Kur J, Wade SD, et al
    Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    J Rheumatol. 2022;49:558-565.
    PubMed     Abstract available

  5. NASH P
    Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available

  6. BESSETTE L, Mysler E, Kinch CD, Kwok K, et al
    Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
    J Rheumatol. 2022;49:566-576.
    PubMed     Abstract available

  7. LUBBERTS E, Scher JU, FitzGerald O
    Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available

    May 2022
  8. CAGNOTTO G, Jacobsson THL, Rydell E, Eberhard A, et al
    Male Sex Predicts a Favorable Outcome in Early ACPA-negative Rheumatoid Arthritis: Data From An Observational Study.
    J Rheumatol. 2022 May 2. pii: jrheum.211199. doi: 10.3899/jrheum.211199.
    PubMed     Abstract available

  9. DIRENZO DD, Robinson S, Bingham CO 3rd, Baer AN, et al
    PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjogren Syndrome.
    J Rheumatol. 2022;49:470-474.
    PubMed     Abstract available

  10. EDER L, Croxford R, Drucker AM, Mendel A, et al
    COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    J Rheumatol. 2022;49:523-530.
    PubMed     Abstract available

  11. WIDDIFIELD J, Eder L, Chen S, Kwong JC, et al
    COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
    J Rheumatol. 2022;49:531-536.
    PubMed     Abstract available

    April 2022
  12. LIAO PY, Liao SL, Liaw YP
    Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.211278. doi: 10.3899/jrheum.211278.
    PubMed     Abstract available

  13. VERWEIJ NJF, de Jongh J, Ter Wee MM, Zwezerijnen GJC, et al
    Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.210928. doi: 10.3899/jrheum.210928.
    PubMed     Abstract available

  14. ZICKUHR L, Mandell BF
    Rheumatology Education Needs a Splash of Color.
    J Rheumatol. 2022;49:343-345.

    March 2022
  15. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
    Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
    PubMed     Abstract available

  16. HADWEN B, Yu R, Cairns E, Barra L, et al
    Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
    PubMed     Abstract available

  17. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status.
    J Rheumatol. 2022;49:340.

  18. HAZLEWOOD GS, Schieir O, Bykerk V, Mujaab K, et al
    Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey.
    J Rheumatol. 2022 Mar 1. pii: jrheum.210688. doi: 10.3899/jrheum.210688.
    PubMed     Abstract available

  19. KREMER JM, Reed G, Pappas DA, Kane K, et al
    Dr. Kremer et al reply.
    J Rheumatol. 2022;49:338-339.

    February 2022
  20. MOVAHEDI M, Cesta A, Li X, Keystone EC, et al
    Physician and Patient Reported Effectiveness are similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data from a Rheumatoid Arthritis Registry.
    J Rheumatol. 2022 Feb 15. pii: jrheum.211066. doi: 10.3899/jrheum.211066.
    PubMed     Abstract available

  21. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
    Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients.
    J Rheumatol. 2022 Feb 1. pii: jrheum.211270. doi: 10.3899/jrheum.211270.
    PubMed     Abstract available

  22. DE ANGELIS R, Giuggioli D, Bajocchi G, Dagna L, et al
    Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
    J Rheumatol. 2022;49:176-185.
    PubMed     Abstract available

  23. BERARDICURTI O, Pavlych V, Cola ID, Ruscitti P, et al
    Long-term Safety of Rituximab in Primary Sjogren Syndrome: The Experience of a Single Center.
    J Rheumatol. 2022;49:171-175.
    PubMed     Abstract available

  24. KAWADA T
    Smoking, Obesity, and Risk of Primary Sjogren Syndrome.
    J Rheumatol. 2022;49:234.

  25. BERTI A, Cornec D, Crowson CS, Matteson EL, et al
    Dr. Berti et al reply.
    J Rheumatol. 2022;49:234.

  26. GRIFFITHS H, Smith T, Mack C, Leadbetter J, et al
    Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset.
    J Rheumatol. 2022;49:150-156.
    PubMed     Abstract available

    January 2022
  27. PAZMINO S, Lovik A, Westhovens R, Verschueren P, et al
    Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication.
    J Rheumatol. 2022 Jan 15. pii: jrheum.210871. doi: 10.3899/jrheum.210871.
    PubMed     Abstract available

  28. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
    Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
    J Rheumatol. 2022;49:122.

    December 2021
  29. KREMER JM, Pappas DA, Kane K, Greenberg J, et al
    The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.
    J Rheumatol. 2021;48:1776-1783.
    PubMed     Abstract available

    November 2021
  30. WIENS D, Smolik I, Meng X, Anaparti V, et al
    Functional disability to evaluate the risk of arthritis in First-degree relatives of Rheumatoid Arthritis patients.
    J Rheumatol. 2021 Nov 1. pii: jrheum.210614. doi: 10.3899/jrheum.210614.
    PubMed     Abstract available

  31. AGUIRRE A, Yazdany J
    Hepatitis B Screening Before Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug Therapy: Many Roads to Improvement.
    J Rheumatol. 2021 Nov 1. pii: jrheum.211000. doi: 10.3899/jrheum.211000.
    PubMed     Abstract available

    October 2021
  32. PINCUS T, Bergman MJ, Yazici Y
    Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?
    J Rheumatol. 2021 Oct 15. pii: jrheum.210953. doi: 10.3899/jrheum.210953.
    PubMed     Abstract available

  33. KRONZER VL, Huang W, Zaccardelli A, Crowson CS, et al
    Association of sinusitis and upper respiratory tract diseases with incident rheumatoid arthritis: A case-control study.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210580. doi: 10.3899/jrheum.210580.
    PubMed     Abstract available

  34. STUDENIC P, Radner H
    Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis.
    J Rheumatol. 2021 Oct 1. pii: jrheum.210984. doi: 10.3899/jrheum.210984.
    PubMed     Abstract available

  35. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission after Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by non-Medicare and Medicare Payer Status.
    J Rheumatol. 2021 Oct 1. pii: jrheum.201370. doi: 10.3899/jrheum.201370.
    PubMed     Abstract available

    September 2021
  36. VAN DER HEIJDE D, Kartman CE, Xie L, Beattie S, et al
    Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND.
    J Rheumatol. 2021 Sep 15. pii: jrheum.210346. doi: 10.3899/jrheum.210346.
    PubMed     Abstract available

  37. FERNANDES BM, Pereira JM, Pereira PR, Bernardes M, et al
    Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept.
    J Rheumatol. 2021 Sep 15. pii: jrheum.210540. doi: 10.3899/jrheum.210540.
    PubMed     Abstract available

    The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review.
    J Rheumatol. 2021 Sep 1. pii: jrheum.210822. doi: 10.3899/jrheum.210822.
    PubMed     Abstract available

  39. BEKKER CL, Bossina S, de Vera MA, Bartlett SJ, et al
    Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study.
    J Rheumatol. 2021;48:1480-1487.
    PubMed     Abstract available

    August 2021
  40. WANG X, Hefton A, Ni K, Ukadike KC, et al
    Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
    PubMed     Abstract available

  41. MEER E, Thrastardottir T, Wang X, Dubreuil M, et al
    Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies.
    J Rheumatol. 2021 Aug 1. pii: jrheum.210006. doi: 10.3899/jrheum.210006.
    PubMed     Abstract available

  42. HAZLEWOOD GS, Bombardier C, Li X, Movahedi M, et al
    Heterogeneity in patient characteristics and differences in treatment across four Canadian rheumatoid arthritis cohorts.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201688. doi: 10.3899/jrheum.201688.
    PubMed     Abstract available

    July 2021
  43. KAHLER J, Mastarone G, Matsumoto R, ZuZero D, et al
    It may help you to know. . .": The early phase qualitative development of a rheumatoid arthritis goal elicitation tool.
    J Rheumatol. 2021 Jul 1. pii: jrheum.201615. doi: 10.3899/jrheum.201615.
    PubMed     Abstract available

  44. JARROT PA, Arcani R, Darmon O, Roudier J, et al
    Axial Articular Manifestations in Primary Sjogren Syndrome: Association With Spondyloarthritis.
    J Rheumatol. 2021;48:1037-1046.
    PubMed     Abstract available

  45. ORNETTI P, Guillier D, Jeudy G
    Perforating Rheumatoid Nodule Mimicking Malignant Soft-tissue Mass of the Forearm.
    J Rheumatol. 2021;48:1103.

  46. YUN H, Xie F, Chen L, Yang S, et al
    Evaluation of the Effect of Diabetes on Rheumatoid Arthritis-related Outcomes in an Electronic Health Record-based Rheumatology Registry.
    J Rheumatol. 2021;48:992-1001.
    PubMed     Abstract available

  47. MCCOY SS, Bartels CM, Saldanha IJ, Bunya VY, et al
    National Sjogren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
    J Rheumatol. 2021;48:1029-1036.
    PubMed     Abstract available

    June 2021
    Is the Gap in Incidence of Cardiovascular Events in Rheumatoid Arthritis Really Closing?
    J Rheumatol. 2021 Jun 15. pii: jrheum.210366. doi: 10.3899/jrheum.210366.
    PubMed     Abstract available

  49. JANSEN G, de Rotte MCFJ, de Jonge R
    Smoking and Methotrexate Inefficacy in Rheumatoid Arthritis: What About Underlying Molecular Mechanisms?
    J Rheumatol. 2021 Jun 15. pii: jrheum.210217. doi: 10.3899/jrheum.210217.
    PubMed     Abstract available

  50. GOULIELMOS GN, Zervou MI
    Risk of Venous Thromboembolism in Ankylosing Spondylitis and Rheumatoid Arthritis: Genetic Aspects.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210131. doi: 10.3899/jrheum.210131.
    PubMed     Abstract available

  51. FERREIRA RJO, Landewe RBM, da Silva JAP
    Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?
    J Rheumatol. 2021 Jun 1. pii: jrheum.210050. doi: 10.3899/jrheum.210050.
    PubMed     Abstract available

    Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210224. doi: 10.3899/jrheum.210224.
    PubMed     Abstract available

    Cutting the "Gordian Knot" - Cardiac Involvement in Primary Sjogren Syndrome.
    J Rheumatol. 2021;48:802-803.

  54. LINDBERG H, Colliander C, Nise L, Dahlqvist J, et al
    Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis With Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study.
    J Rheumatol. 2021;48:894-897.
    PubMed     Abstract available

  55. NISHIWAKI A, Kobayashi H, Ikumi N, Kobayashi Y, et al
    Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjogren Syndrome Assessed by a Cardiac Magnetic Resonance Approach.
    J Rheumatol. 2021;48:859-866.
    PubMed     Abstract available

    May 2021
  56. JACOBS JWG, Verhoeven MMA, Welsing PMJ
    Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests.
    J Rheumatol. 2021 May 15. pii: jrheum.201510. doi: 10.3899/jrheum.201510.
    PubMed     Abstract available

  57. PIANAROSA E, Hazlewood G, Thomas M, Hsiao R, et al
    Supporting Equity in Rheumatoid Arthritis Outcomes in Canada: Population-Specific Factors in Patient-Centered Care.
    J Rheumatol. 2021 May 15. pii: jrheum.210016. doi: 10.3899/jrheum.210016.
    PubMed     Abstract available

  58. RAMPES S, Patel V, Bosworth A, Jacklin C, et al
    Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis.
    J Rheumatol. 2021 May 15. pii: jrheum.201439. doi: 10.3899/jrheum.201439.
    PubMed     Abstract available

  59. TANIGUCHI Y, Kimata T
    Yellow Nail Syndrome Associated With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:785.

  60. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
    Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (Biobadabrasil).
    J Rheumatol. 2021 May 1. pii: jrheum.201248. doi: 10.3899/jrheum.201248.
    PubMed     Abstract available

  61. JOHANSSON FD, Collins JE, Yau V, Guan H, et al
    Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning.
    J Rheumatol. 2021 May 1. pii: jrheum.201626. doi: 10.3899/jrheum.201626.
    PubMed     Abstract available

  62. LIU Y, Zhang S, Xia CS, Chen J, et al
    Elevated Granulocyte Colony-stimulating Factor Levels in Patients With Active Phase of Adult-onset Still Disease.
    J Rheumatol. 2021;48:664-668.
    PubMed     Abstract available

    April 2021
  63. TANAKA Y, Takeuchi T, Soen S, Yamanaka H, et al
    Effects of denosumab in Japanese rheumatoid arthritis patients treated with conventional anti-rheumatic drugs: 36-month extension of a phase 3 study.
    J Rheumatol. 2021 Apr 15. pii: jrheum.201376. doi: 10.3899/jrheum.201376.
    PubMed     Abstract available

  64. KARLSSON SUNDBAUM J, Arkema EV, Bruchfeld J, Jonsson J, et al
    Tuberculosis in biologic-naive patients with rheumatoid arthritis - risk factors and tuberculosis characteristics.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201251. doi: 10.3899/jrheum.201251.
    PubMed     Abstract available

  65. LIANG YT, Leong PY, Wei JC
    Questions on the Bidirectional Relationship Between Primary Sjogren Syndrome and Non-Hodgkin Lymphoma.
    J Rheumatol. 2021;48:620.

    March 2021
  66. BEAUMONT JL, Davis ES, Fries JF, Curtis JR, et al
    Meaningful change thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue and pain interference scores in patients with rheumatoid arthritis.
    J Rheumatol. 2021 Mar 15. pii: jrheum.200990. doi: 10.3899/jrheum.200990.
    PubMed     Abstract available

  67. NIKIPHOROU E, Ibrahim F, Scott DL
    Rheumatoid Arthritis Real-world Management Over 20 Years.
    J Rheumatol. 2021 Mar 15. pii: jrheum.201189. doi: 10.3899/jrheum.201189.
    PubMed     Abstract available

    Methotrexate and Cardiovascular Disease in Patients With Rheumatoid Arthritis: Insights and Novel Speculations.
    J Rheumatol. 2021 Mar 15. pii: jrheum.201415. doi: 10.3899/jrheum.201415.
    PubMed     Abstract available

  69. VERHOEVEN MMA, Westgeest AAA, Jacobs JWG
    A Sex Difference in HandScan Scores in Rheumatoid Arthritis Patients and Controls? An Ongoing Analysis of the Sex Difference and Other Potential Confounders.
    J Rheumatol. 2021 Mar 15. pii: jrheum.201555. doi: 10.3899/jrheum.201555.
    PubMed     Abstract available

  70. CHATZIDIONYSIOU K, Hetland ML, Frisell T, Di Giuseppe D, et al
    Effectiveness of a second biologic after failure of a non-tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201467. doi: 10.3899/jrheum.201467.
    PubMed     Abstract available

    Defeating the Hydra of Excess Cardiovascular Disease Risk in Rheumatoid Arthritis - How Close Are We to Completing the Task?
    J Rheumatol. 2021 Mar 1. pii: jrheum.201110. doi: 10.3899/jrheum.201110.
    PubMed     Abstract available

    Ultrasonography of the Salivary Gland in Primary Sjogren Syndrome: Usefulness to Phenotype the Patients.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201433. doi: 10.3899/jrheum.201433.
    PubMed     Abstract available

    February 2021
  73. MYASOEDOVA E, Davis JM 3rd, Roger VL, Achenbach SJ, et al
    Improved Incidence of Cardiovascular Disease in Patients with Incident Rheumatoid Arthritis in the 2000s: a Population-Based Cohort Study.
    J Rheumatol. 2021 Feb 15. pii: jrheum.200842. doi: 10.3899/jrheum.200842.
    PubMed     Abstract available

  74. GUNDERSON TM, Myasoedova E, Davis JM 3rd, Crowson CS, et al
    Multimorbidity Burden in Rheumatoid Arthritis: A Population-Based Cohort Study.
    J Rheumatol. 2021 Feb 15. pii: jrheum.200971. doi: 10.3899/jrheum.200971.
    PubMed     Abstract available

  75. OCHI S, Mizoguchi F, Nakano K, Tanaka Y, et al
    Similarity of response to biologics between elderly-onset rheumatoid arthritis (EORA) and non-EORA elderly patients: from the FIRST registry.
    J Rheumatol. 2021 Feb 15. pii: jrheum.201135. doi: 10.3899/jrheum.201135.
    PubMed     Abstract available

  76. KAVANAUGH A, Westhovens RR, Winthrop KL, Lee SJ, et al
    Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs.
    J Rheumatol. 2021 Feb 1. pii: jrheum.201183. doi: 10.3899/jrheum.201183.
    PubMed     Abstract available

    January 2021
  77. SOROUR AA, Kurmann RD, Shahin YE, Crowson CS, et al
    Use of Hydroxychloroquine And Risk of Heart Failure in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2021 Jan 15. pii: jrheum.201180. doi: 10.3899/jrheum.201180.
    PubMed     Abstract available

  78. MILLER JB, Baer AN
    Hyperviscosity Syndrome in Rheumatoid Arthritis.
    J Rheumatol. 2021 Jan 15. pii: jrheum.200591. doi: 10.3899/jrheum.200591.
    PubMed     Abstract available

  79. WILTON KM, Achenbach SJ, Davis JM 3rd, Myasoedova E, et al
    Erectile Dysfunction and Cardiovascular Risk in Men with Rheumatoid Arthritis: A Population- Based Cohort Study.
    J Rheumatol. 2021 Jan 15. pii: jrheum.201226. doi: 10.3899/jrheum.201226.
    PubMed     Abstract available

    Questions From Patients and Doctors on Negative Minor Salivary Gland Biopsy in Sjogren Syndrome.
    J Rheumatol. 2021;48:149.

  81. MONSALVE DM, Anaya JM
    Drs. Monsalve and Anaya reply.
    J Rheumatol. 2021;48:149.

    December 2020
  82. PATHI A, Wright M, Smed MK, Nelson JL, et al
    The rheumatoid arthritis gene expression signature among women who improve or worsen during pregnancy - a pilot study.
    J Rheumatol. 2020 Dec 15. pii: jrheum.201128. doi: 10.3899/jrheum.201128.
    PubMed     Abstract available

  83. VU M, Carvalho N, Clarke PM, Buchbinder R, et al
    Impact of comorbid conditions on health care expenditure and work-related outcomes in patients with rheumatoid arthritis.
    J Rheumatol. 2020 Dec 15. pii: jrheum.200231. doi: 10.3899/jrheum.200231.
    PubMed     Abstract available

  84. PUSZTAI A, Hamar A, Horvath A, Gulyas K, et al
    Soluble vascular biomarkers in rheumatoid arthritis and ankylosing spondylitis: effects of one-year anti-TNF-alpha therapy.
    J Rheumatol. 2020 Dec 15. pii: jrheum.200916. doi: 10.3899/jrheum.200916.
    PubMed     Abstract available

  85. GENOVESE M, Spindler A, Sagawa A, Park W, et al
    Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase-Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase-2 Study.
    J Rheumatol. 2020 Dec 15. pii: jrheum.200893. doi: 10.3899/jrheum.200893.
    PubMed     Abstract available

  86. SUGAWARA E, Matsui K, Amasaki Y
    Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib.
    J Rheumatol. 2020;47:1835-1836.

  87. DESSEIN PH, Stanwix AE, Solomon A
    Could Disease Activity Score in 28 Joints-Gamma-glutamyl Transferase Use Improve Cardiovascular Disease Risk Management in Rheumatoid Arthritis?
    J Rheumatol. 2020;47:1729-1731.

  88. CAFARO G, Gerli R, Bartoloni E
    Association Between Glandular Infiltrate and Leukopenia in Sjogren Syndrome (SS): Data From the Italian Research Group on SS (GRISS).
    J Rheumatol. 2020;47:1840-1841.

  89. RASMUSSEN A, Scofield RH
    Drs. Rasmussen and Scofield reply.
    J Rheumatol. 2020;47:1841.

  90. RASMUSSEN A, Scofield RH
    Drs. Rasmussen and Scofield reply.
    J Rheumatol. 2020;47:1839.

  91. CARUBBI F, Alunno A
    The Serological Status Affects the Prognostic Role of Salivary Gland Histology in Primary Sjogren Syndrome.
    J Rheumatol. 2020;47:1838.

    November 2020
  92. KRONZER VL, Huang W, Dellaripa PF, Huang S, et al
    Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200863. doi: 10.3899/jrheum.200863.
    PubMed     Abstract available

  93. PAZMINO S, Lovik A, Boonen A, De Cock D, et al
    Including pain, fatigue and physical function when assessing patients with early rheumatoid arthritis provides a comprehensive picture of disease burden.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200758. doi: 10.3899/jrheum.200758.
    PubMed     Abstract available

  94. RATHBUN AM, England BR, Mikuls TR, Ryan AS, et al
    Relationship between Depression and Disease Activity in United States Veterans with Early Rheumatoid Arthritis Receiving Methotrexate.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200743. doi: 10.3899/jrheum.200743.
    PubMed     Abstract available

  95. BARBER CEH, Lacaille D, Hall M, Bohm V, et al
    Priorities for High Quality Care in Rheumatoid Arthritis: Results of Patient, Health Professional, and Policymaker Perspectives.
    J Rheumatol. 2020 Nov 15. pii: jrheum.201044. doi: 10.3899/jrheum.201044.
    PubMed     Abstract available

  96. QIU W, Liu Y
    DNA Methylation of the MHC Region in Rheumatoid Arthritis: Perspectives and Challenges.
    J Rheumatol. 2020;47:1597-1599.

  97. GOULD PW, Zemel BS, Taratuta EG, Baker JF, et al
    Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations with Disease Characteristics, Body Composition, and Physical Functioning.
    J Rheumatol. 2020 Nov 1. pii: jrheum.200673. doi: 10.3899/jrheum.200673.
    PubMed     Abstract available

    October 2020
  98. MARGOLIS DJ, Mitra N, Monos DS
    Rheumatoid Arthritis Known HLA Associations are Unlikely To Be Associated With Atopic Dermatitis.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200583. doi: 10.3899/jrheum.200583.
    PubMed     Abstract available

  99. BANDER ALMUTAIRI K, Nossent JC, Preen DB, Keen HI, et al
    The prevalence of Rheumatoid Arthritis: A systematic review of population-based studies.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200367. doi: 10.3899/jrheum.200367.
    PubMed     Abstract available

  100. BOERS M, Pincus T
    Long-term Glucocorticoid Use in Rheumatoid Arthritis.
    J Rheumatol. 2020 Oct 15. pii: jrheum.201137. doi: 10.3899/jrheum.201137.
    PubMed     Abstract available

  101. XIE F, Chen L, Yun H, Levitan EB, et al
    Benefits of Methotrexate Use on Cardiovascular Disease Risk among Rheumatoid Arthritis Patients Initiating Biologic Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2020 Oct 15. pii: jrheum.191326. doi: 10.3899/jrheum.191326.
    PubMed     Abstract available

  102. FISHER A, Hudson M, Platt RW, Dormuth CR, et al
    Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study.
    J Rheumatol. 2020 Oct 1. pii: jrheum.191252. doi: 10.3899/jrheum.191252.
    PubMed     Abstract available

  103. SINGH JA, Cleveland JD
    Time-trends in Opioid Use Disorder Hospitalizations in Gout, Rheumatoid arthritis, Fibromyalgia, Osteoarthritis, and Low Back Pain.
    J Rheumatol. 2020 Oct 1. pii: jrheum.191370. doi: 10.3899/jrheum.191370.
    PubMed     Abstract available

  104. MOKUDA S, Tokunaga T, Masumoto J, Sugiyama E, et al
    Angiotensin-converting Enzyme 2, a SARS-CoV-2 Receptor, Is Upregulated by Interleukin 6 through STAT3 Signaling in Synovial Tissues.
    J Rheumatol. 2020;47:1593-1595.

  105. MOSSEL E, van Nimwegen JF, Stel AJ, Wijnsma RF, et al
    Clinical phenotyping of primary Sjogren's patients using salivary gland ultrasonography - data from the RESULT cohort.
    J Rheumatol. 2020 Oct 1. pii: jrheum.200482. doi: 10.3899/jrheum.200482.
    PubMed     Abstract available

    September 2020
  106. FINZEL S, Manske SL, Barnabe C, Burghardt AJ, et al
    Reliability and Change in Erosion Measurements by High-Resolution peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis Patients.
    J Rheumatol. 2020 Sep 15. pii: jrheum.191391. doi: 10.3899/jrheum.191391.
    PubMed     Abstract available

  107. BARBER CEH, Lacaille D, Faris P, Mosher D, et al
    Evaluating quality of care for rheumatoid arthritis for the population of Alberta using system-level performance measures.
    J Rheumatol. 2020 Sep 15. pii: jrheum.200420. doi: 10.3899/jrheum.200420.
    PubMed     Abstract available

  108. BARBER CEH, Then KL, Bohm V, Hall M, et al
    Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200688. doi: 10.3899/jrheum.200688.
    PubMed     Abstract available

    August 2020
  109. OZEN G, Pedro S, Michaud K
    The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis.
    J Rheumatol. 2020 Aug 15. pii: jrheum.200265. doi: 10.3899/jrheum.200265.
    PubMed     Abstract available

  110. GROSSE J, Allado E, Albuisson E, Pierreisnard A, et al
    The USSe (UltraSound Score for Erosions) in the evaluation of bone erosions in RA compared to the SHSe (Van der Heijde-modified Sharp score for erosions).
    J Rheumatol. 2020 Aug 15. pii: jrheum.200286. doi: 10.3899/jrheum.200286.
    PubMed     Abstract available

  111. HANLY JG, Lethbridge L
    Disease modifying anti-rheumatic drugs, biologics and corticosteroid use in older patients with rheumatoid arthritis over 20 years.
    J Rheumatol. 2020 Aug 1. pii: jrheum.200310. doi: 10.3899/jrheum.200310.
    PubMed     Abstract available

  112. VERHOEVEN MMA, Tekstra J, van Laar JM, Petho-Schramm A, et al
    Impact on costs and quality-adjusted-life-years of treat-to-target treatment strategies initiating methotrexate, or tocilizumab, or their combination in early rheumatoid arthritis. 5 year economic evaluation.
    J Rheumatol. 2020 Aug 1. pii: jrheum.200067. doi: 10.3899/jrheum.200067.
    PubMed     Abstract available

    July 2020
  113. MARCHAND NE, Sparks JA, Tedeschi SK, Malspeis S, et al
    Abdominal Obesity in Comparison with General Obesity and Risk of Developing Rheumatoid Arthritis in Women.
    J Rheumatol. 2020 Jul 15. pii: jrheum.200056. doi: 10.3899/jrheum.200056.
    PubMed     Abstract available

    June 2020
  114. FOERS AD, Garnham AL, Smyth GK, Proudman SM, et al
    Circulating small non-coding RNA biomarkers of response to triple DMARD therapy in Caucasian women with early rheumatoid arthritis.
    J Rheumatol. 2020 Jun 15. pii: jrheum.191012. doi: 10.3899/jrheum.191012.
    PubMed     Abstract available

  115. POULSEN AE, Axelsen MB, Poggenborg RP, Eshed I, et al
    Whole-Body MRI in Psoriatic Arthritis, Rheumatoid Arthritis And Healthy Controls - Interscan, Intrareader and Interreader Agreement and Distribution of Lesions.
    J Rheumatol. 2020 Jun 15. pii: jrheum.200084. doi: 10.3899/jrheum.200084.
    PubMed     Abstract available

  116. QUEVEDO-ABELEDO JC, Sanchez-Perez H, Tejera-Segura B, de Armas-Rillo L, et al
    Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jun 15. pii: jrheum.200435. doi: 10.3899/jrheum.200435.
    PubMed     Abstract available

    May 2020
  117. TURK MA, Hayworth JL, Nevskaya T, Pope JE, et al
    Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis.
    J Rheumatol. 2020 May 1. pii: jrheum.190768. doi: 10.3899/jrheum.190768.
    PubMed     Abstract available

  118. SLIM Z, Bernatsky S
    Z. Slim and S. Bernatsky reply.
    J Rheumatol. 2020;47:781.

  119. SAHINKAYA Y, Mumcu G, Ozdemir FT, Kurus RE, et al
    Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health Related Quality of Life in Sjogren's syndrome?
    J Rheumatol. 2020 May 1. pii: jrheum.190849. doi: 10.3899/jrheum.190849.
    PubMed     Abstract available

    April 2020
  120. TRIANTAFYLLIAS K, Heller C, de Blasi M, Galle PR, et al
    Diagnostic value of optical spectral transmission in rheumatoid arthritis: associations with clinical characteristics and comparison with joint ultrasonography.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190650. doi: 10.3899/jrheum.190650.
    PubMed     Abstract available

    March 2020
  121. MONSALVE DM, Anaya JM
    With Minor Salivary Gland Biopsy in Sjogren Syndrome, Is a Negative Result Possible?
    J Rheumatol. 2020;47:310-312.

    February 2020
  122. POLACHEK A, Eder L
    Pregnancy Outcome in Inflammatory Arthropathies - Are Population Database Studies the Right Tool?
    J Rheumatol. 2020;47:161-163.

  123. DEANE KD, Demoruelle MK
    Drs. Deane and Demoruelle reply.
    J Rheumatol. 2020;47:300.

  124. WARD JM, Hess JN, Davis LS
    Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    J Rheumatol. 2020;47:298-299.

    January 2020
  125. MAVRAGANI CP, Moutsopoulos HM
    Drs. Mavragani and Moutsopoulos reply.
    J Rheumatol. 2020;47:158.

  126. KILLIAN M, Batteux F, Paul S
    The MRL/lpr Mouse Model: An Important Animal Model for Systemic Sjogren Syndrome and Polyautoimmunity.
    J Rheumatol. 2020;47:157.

    September 2019
  127. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
    Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
    PubMed     Abstract available

    August 2019
  128. RENNER N, Kleyer A, Kronke G, Simon D, et al
    T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in RA.
    J Rheumatol. 2019 Aug 15. pii: jrheum.180728. doi: 10.3899/jrheum.180728.
    PubMed     Abstract available

    June 2019
  129. WONG PC, Lee G, Sedie AD, Hanova P, et al
    Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181087. doi: 10.3899/jrheum.181087.
    PubMed     Abstract available

    March 2019
  130. TERSLEV L, Naredo E, Keen HI, Bruyn GAW, et al
    The OMERACT stepwise approach to select and develop imaging outcome measurement instruments: the musculoskeletal ultrasound example.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181158. doi: 10.3899/jrheum.181158.
    PubMed     Abstract available

    February 2019
  131. KRABBE S, Eshed I, Gandjbakhch F, Pedersen SJ, et al
    Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE).
    J Rheumatol. 2019 Feb 15. pii: jrheum.181084. doi: 10.3899/jrheum.181084.
    PubMed     Abstract available

    January 2019
  132. MANSKE SL, Brunet SC, Finzel S, Stok KS, et al
    The SPECTRA Collaboration OMERACT Working Group: Criterion Validity of Joint Space Outcomes with High Resolution Peripheral Quantitative Computed Tomography.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180870. doi: 10.3899/jrheum.180870.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.